Julia C. Ford

Also affiliated with Oregon Health & Science University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Cytomegaloviral determinants of CD8 + T cell programming and RhCMV/SIV vaccine efficacy”.

Cytomegaloviral determinants of CD8 + T cell programming and RhCMV/SIV vaccine efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.30.321349

N/A

0DataRank · unranked

3 citations

Scott G. Hansen, Meaghan H. Hancock, Colette M. Hughes, Julia C. Ford, Roxanne M. Gilbride +25 more

Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy

Science(2021)10.1126/science.abe9233

N/A

0DataRank · unranked

60 citations

Scott G. Hansen, Ravi Iyer, Nessy John, Daniel Malouli, David Morrow +21 more

Cytomegaloviral determinants of CD8 + T cell programming and RhCMV/SIV vaccine efficacy

Science Immunology(2021)10.1126/sciimmunol.abg5413

N/A

0DataRank · unranked

55 citations

Scott G. Hansen, Meaghan H. Hancock, Colette M. Hughes, Julia C. Ford, Roxanne M. Gilbride +25 more

Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy

PLoS Pathogens(2021)10.1371/journal.ppat.1009278

N/A

0DataRank · unranked

32 citations

Scott G. Hansen, G. Lynn Law, Connor Driscoll, Richard Green, Elise Smith +33 more

Sustained IL-15 response signature predicts RhCMV/SIV vaccine efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.11.426199

N/A

0DataRank · unranked

1 citations

Scott G. Hansen, G. Lynn Law, Connor Driscoll, Richard Green, Elise Smith +33 more

Myeloid cell tropism enables MHC-E–restricted CD8 + T cell priming and vaccine efficacy by the RhCMV/SIV vaccine

Science Immunology(2022)10.1126/sciimmunol.abn9301

N/A

0DataRank · unranked

40 citations

Meaghan H. Hancock, Daniel Malouli, Emily E. Marshall, Colette M. Hughes, Kurt T. Randall +24 more

Late gene expression–deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV

JCI Insight(2023)10.1172/jci.insight.164692

N/A

0DataRank · unranked

11 citations

Jennie Womack, Wilma Perez, Kimberli A. Schmidt, Emily E. Marshall, Ravi Iyer +20 more

Human cytomegalovirus UL18 prevents priming of MHC-E– and MHC-II–restricted CD8 + T cells

Science Immunology(2024)10.1126/sciimmunol.adp5216

N/A

0DataRank · unranked

9 citations

Husam Taher, Mandana Mansouri, Ravi Iyer, Jason S. Reed, Courtney R. Papen +16 more

Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques

Frontiers in Immunology(2024)10.3389/fimmu.2024.1444621

N/A

0DataRank · unranked

0 citations

Justine Sunshine, GW McElfresh, Jason S. Reed, Reese Pathak, Katherine B. Bateman +9 more

Glycoprotein L–deleted single-cycle rhesus cytomegalovirus vectors elicit MHC-E–restricted CD8+ T cells that protect against SIV

The Journal of Immunology(2025)10.1093/jimmun/vkaf104

N/A

0DataRank · unranked

4 citations

John B. Schell, Emily E. Marshall, Sohita Ojha, Shana Feltham, David Morrow +19 more